HIGHLIGHTS
- who: Aitor Benedicto and collaborators from the Department of Cell Biology and Histology, School of Medicine and Nursing, University of the have published the research: Ocoxin Increases the Antitumor Effect of BRAF Inhibition and Reduces Cancer Associated Fibroblast-Mediated Chemoresistance and Protumoral Activity in Metastatic Melanoma, in the Journal: Nutrients 2021, 13, x FOR PEER REVIEW of 12/Dec/2020
- what: Due to the wide spectrum of antitumor capacities demonstrated by Ocoxin, the authors aimed to evaluate the antitumor potential of this compound in the progression of metastatic melanoma, its possible synergic effect with the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.